Formulation-component study
PCSO-524® — Mickleborough et al., 2015
- Randomized
- Placebo-controlled
- 32 untrained men
- 30-day supplementation
A randomized placebo-controlled study investigated a PCSO-524® oil blend in 32 untrained men, supplemented for 26 days before downhill running and for 96 hours afterward. The study assessed indirect markers of muscle damage, inflammatory markers and functional measures. Its abstract describes 1,200 mg/day of the blend; the methods specify eight capsules supplying 400 mg lipid extract plus 800 mg olive oil daily. This was not the complete Lyprinol® Advanced Sport Edition formulation.
Study limitations and context
The small, male-only, untrained population and short, experimentally induced exercise protocol limit generalisation to athletes or routine product use. The intervention and study dose differ from the finished Sport Edition product. Pharmalink International Ltd. funded the study; the authors reported no competing interests and stated that the funder had no role in design, analysis, writing or publication decisions. These findings do not establish faster recovery or treatment of injury, inflammation or pain.
Mickleborough TD, Sinex JA, Platt D, Chapman RF, Hirt M. The effects PCSO-524®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial. Journal of the International Society of Sports Nutrition. 2015;12:10. DOI: 10.1186/s12970-015-0073-z
